Regenerative medicines
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT05585606
Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 19, 2022
Completion: Jan 31, 2026
Loading map...